Xenon Pharmaceuticals (NASDAQ:XENE) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Xenon Pharmaceuticals missed estimated earnings by 1.61%, reporting an EPS of $-0.63 versus an estimate of $-0.62.
Revenue was down $8.77 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.01 which was followed by a 7.39% drop in the share price the next day.
Here's a look at Xenon Pharmaceuticals's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.58 | -0.52 | -0.48 | -0.41 |
| EPS Actual | -0.57 | -0.57 | -0.55 | -0.35 |
| Revenue Estimate | 2.28M | 3.02M | 3.55M | 8.70M |
| Revenue Actual | 0 | 132K | 536K | 8.77M |
To track all earnings releases for Xenon Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
